Vimarsana
Biggest News Aggregation in the World

Page 30 - Structural Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Heart Today - Breaking & Trending Today

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND'S INNOVESTOR LIFE SCIENCE FUND AND TESI - Vimarsana News

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND'S INNOVESTOR LIFE SCIENCE FUND AND TESI

/PRNewswire/ -- HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve...

Cardiovascular Research Foundation Announces Clinical Trials Center Executive Director - Vimarsana News

Cardiovascular Research Foundation Announces Clinical Trials Center Executive Director

The Cardiovascular Research Foundation (CRF) recently announced that Alexandra Popma, MD has been named its Clinical Trials Center Executive Director. 

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE - Vimarsana News

EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

/PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology...

Medtronic's Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting - Vimarsana News

Medtronic's Next-Gen Evolut FX TAVR System Shows Significant Improvement in Commissure Alignment in Real World Setting

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration 

Medtronic reports positive study results for next-gen TAVR system - Vimarsana News

Medtronic reports positive study results for next-gen TAVR system

Medtronic (NYSE:MDT) today presented positive results for its next-generation transcatheter aortic valve replacement (TAVR) system.